Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease

BACKGROUND: Safety of thioguanine in pregnant patients with inflammatory bowel disease [IBD] is sparsely recorded. This study was aimed to document the safety of thioguanine during pregnancy and birth. METHODS: In this multicentre case series, IBD patients treated with thioguanine during pregnancy w...

Descripción completa

Detalles Bibliográficos
Autores principales: Crouwel, Femke, Simsek, Melek, de Boer, Marjon A, Mulder, Chris J J, van Andel, Emma M, Creemers, Rob H, van Asseldonk, Dirk P, van Bodegraven, Ad A, Horjus, Carmen S, Visschedijk, Marijn C, Weusthuis, Angelique L M, Seinen, Margien L, Jharap, Bindia, van Schaik, Fiona D M, Ahmad, Ishfaq, Boekema, Paul J, Tack, Greetje J, Wormmeester, Louktje, Lutgens, Maurice W M D, van Boeckel, Petra G A, Gilissen, Lennard P L, Kerkhof, Marjon, Russel, Maurice G V M, Hoentjen, Frank, Bartelink, Maartje E, Kuijvenhoven, Johan P, Maljaars, Jeroen W J, van Dop, Willemijn A, Wonders, Janneke, van der Voorn, Michael M P J A, Buiter, Hans J C, de Boer, Nanne K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155742/
https://www.ncbi.nlm.nih.gov/pubmed/36521000
http://dx.doi.org/10.1093/ecco-jcc/jjac183

Ejemplares similares

Ejemplares similares